Autotaxin is a potential link between genetic risk factors and immunological disturbances of plasmacytoid dendritic cells in systematic lupus erythematosus

Background The importance of autotaxin, an enzyme that catalyzes lysophospholipid production, has recently been recognized in various diseases, including cancer and autoimmune diseases. Herein, we examined the role of autotaxin in systemic lupus erythematosus (SLE), utilizing data from ImmuNexUT, a comprehensive database consisting of transcriptome data and expression quantitative trait locus (eQTL) data of immune cells from patients with immune-mediated disorders. Methods Serum autotaxin concentrations in patients with SLE and healthy controls (HCs) were compared. The transcriptome data of patients with SLE and age- and sex-matched HCs were obtained from ImmuNexUT. The expression of ENPP2, the gene encoding autotaxin, was examined in peripheral blood immune cells. Next, weighted gene correlation network analysis (WGCNA) was performed to identify genes with expression patterns similar to ENPP2. The ImmuNexUT eQTL database and public epigenomic databases were used to infer the relationship between autotaxin and pathogenesis of SLE. Results Autotaxin levels were elevated in the serum of patients with SLE compared to HCs. Furthermore, the expression of ENPP2 was higher in plasmacytoid dendritic cells (pDCs) than in other immune cell subsets, and its expression was elevated in pDCs of patients with SLE compared to HCs. In WGCNA, ENPP2 belonged to a module that correlated with disease activity. This module was enriched in interferon-associated genes and included genes whose expression was influenced by single-nucleotide polymorphisms associated with SLE, suggesting that it is a key module connecting genetic risk factors of SLE with disease pathogenesis. Analysis utilizing the ImmuNexUT eQTL database and public epigenomic databases suggested that the increased expression of ENPP2 in pDCs from patients with SLE may be caused by increased expression of interferon-associated genes and increased binding of STAT3 complexes to the regulatory region of ENPP2. Conclusions Autotaxin may play a critical role in connecting genetic risk factors of SLE to disease pathogenesis in pDCs.

[1]  V. Aidinis,et al.  Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells , 2021, medRxiv.

[2]  Y. Okada,et al.  Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases , 2021, Cell.

[3]  M. Kurano,et al.  Higher serum levels of autotaxin and phosphatidylserine‐specific phospholipase A1 in patients with lupus nephritis , 2020, International journal of rheumatic diseases.

[4]  Michael J. Purcaro,et al.  Expanded encyclopaedias of DNA elements in the human and mouse genomes , 2020, Nature.

[5]  M. Kurano,et al.  Urinary autotaxin concentrations are associated with kidney injury. , 2020, Clinica chimica acta; international journal of clinical chemistry.

[6]  Systemic Lupus Erythematosus Disease Activity Index , 2020, Definitions.

[7]  Phillip A. Richmond,et al.  JASPAR 2020: update of the open-access database of transcription factor binding profiles , 2019, Nucleic Acids Res..

[8]  Thawfeek M. Varusai,et al.  The reactome pathway knowledgebase , 2019, Nucleic Acids Res..

[9]  V. Aidinis,et al.  Autotaxin and chronic inflammatory diseases. , 2019, Journal of autoimmunity.

[10]  T. Sawada,et al.  Serum phosphatidylserine‐specific phospholipase A1 as a novel biomarker for monitoring systemic lupus erythematosus disease activity , 2019, International journal of rheumatic diseases.

[11]  Z. Rahman,et al.  The Post-GWAS Era: How to Validate the Contribution of Gene Variants in Lupus , 2019, Current Rheumatology Reports.

[12]  David A. Knowles,et al.  Landscape of stimulation-responsive chromatin across diverse human immune cells , 2018, Nature Genetics.

[13]  M. Kurano,et al.  Association between serum autotaxin or phosphatidylserine‐specific phospholipase A1 levels and melanoma , 2018, The Journal of dermatology.

[14]  Lihui Wei,et al.  ATX-LPA axis facilitates estrogen-induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway , 2018, Molecular medicine reports.

[15]  M. Govoni,et al.  Application of SLICC classification criteria in undifferentiated connective tissue disease and evolution in systemic lupus erythematosus: analysis of a large monocentric cohort with a long-term follow-up , 2017, Lupus.

[16]  J. Rioux,et al.  Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus , 2015, Nature Genetics.

[17]  Ming Guan,et al.  Type I Interferons Function as Autocrine and Paracrine Factors to Induce Autotaxin in Response to TLR Activation , 2015, PloS one.

[18]  M. Kurano,et al.  A New Enzyme Immunoassay for the Quantitative Determination of Classical Autotaxins (ATXα, ATXβ, and ATXγ) and Novel Autotaxins (ATXδ and ATXε) , 2015, PloS one.

[19]  J. Molineros,et al.  Evaluation of SLE Susceptibility Genes in Malaysians , 2014, Autoimmune diseases.

[20]  Manolis Kellis,et al.  Systematic discovery and characterization of regulatory motifs in ENCODE TF binding experiments , 2013, Nucleic acids research.

[21]  Brad T. Sherman,et al.  DAVID-WS: a stateful web service to facilitate gene/protein list analysis , 2012, Bioinform..

[22]  R. Durbin,et al.  Using probabilistic estimation of expression residuals (PEER) to obtain increased power and interpretability of gene expression analyses , 2012, Nature Protocols.

[23]  Manolis Kellis,et al.  HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..

[24]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[25]  M. Kurokawa,et al.  Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma , 2008, British journal of haematology.

[26]  M. Nangaku,et al.  Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[27]  E. Goetzl,et al.  Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. , 2002, Biochimica et biophysica acta.

[28]  D. Gladman,et al.  Systemic lupus erythematosus disease activity index 2000. , 2002, The Journal of rheumatology.

[29]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.